International Society for Heart Research

Last updated

The International Society for Heart Research began as an "International Study Group for Research in Cardiac Metabolism" in Dubrovnik in 1968; at the 1976 World Congress in Tokyo, it adopted the name "International Society for Heart Research". It currently has over 3,000 members and comprises 7 international Sections (Australasian, Chinese, European, Indian, Japanese, Latin American and North American). The current president is Dr. Yoshihiko Saito Nara.

The Society publishes its own journal ( Journal of Molecular and Cellular Cardiology [1] ) and newsletter (Heart News and Views [2] ).

The ISHR has developed a number of awards (Peter Harris Distinguished Scientist Award, Research Achievement Award, Outstanding Investigator Award, three named Distinguished Lecture Awards and Distinguished Leader Award for Faculty). [3] It also gives the Richard J. Bing Award for Young Investigators, an award named after its first President and founder.

Related Research Articles

Naranjan S. Dhalla, is a Canadian cardiovascular research scientist focusing on cardiovascular pathophysiology and therapy of heart disease. His laboratory employs a variety of experimental models to investigate a wide range of cardiovascular diseases at the subcellular and molecular levels.

<span class="mw-page-title-main">American Society for Biochemistry and Molecular Biology</span> Organization founded in 1906

The American Society for Biochemistry and Molecular Biology (ASBMB) is a learned society that was founded on December 26, 1906, at a meeting organized by John Jacob Abel. The roots of the society were in the American Physiological Society, which had been formed some 20 years earlier. ASBMB is the US member of the International Union of Biochemistry and Molecular Biology.

Abdul Jamil Tajik is a Pakistani American physician and medical investigator in the field of cardiovascular diseases. He is listed by the Institute for Scientific Information as a highly cited researcher – one of the top 250 researchers in his field in terms of number of citations.

Stefanie Dimmeler is a German biologist specializing in the pathophysiological processes underlying cardiovascular diseases. Her awards and honours include the Gottfried Wilhelm Leibniz Prize of the German Research Foundation for her work on the programmed cell death of endothelial cells. Since 2008 she has led the Institute for Cardiovascular Regeneration at the University of Frankfurt. Her current work is focusing to develop cellular and pharmacological strategies to improve cardiovascular repair and regeneration. Her work aims to establish non-coding RNAs as novel therapeutic targets.

Govindan Vijayaraghavan is a cardiologist from India, credited with establishing the first 2D Echocardiography laboratory in India. He is the vice-chairman & Founder Director of the Kerala Institute of Medical Sciences and the President of the Society for Continuing Medical Education and Research, Trivandrum, Kerala. He was honoured by Government of India in 2009 for his services in the field of medical sciences by awarding him Padmashri.

<span class="mw-page-title-main">Frank Bengel</span>

Frank Michael Bengel is a German professor and nuclear medicine physician. He is the current director of the Department of Nuclear Medicine at the Hannover Medical School.

<span class="mw-page-title-main">Charles Antzelevitch</span> American cardiovascular research scientist

Charles Antzelevitch is an American cardiovascular research scientist in the fields of cardiac electrophysiology and cardiac arrhythmia syndromes.

B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.

Rhian M. Touyz Koppel MBBCh, MSc (Med), PhD, FRCP, FRSE, FMedSci, FCAHS is a Canadian medical researcher. She is currently serving as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021. A clinician scientist, her research primarily focuses on hypertension and cardiovascular disease.

<span class="mw-page-title-main">David A. Eisner</span>

David Alfred Eisner, FRCP (Hon), FMedSci, is British Heart Foundation Professor of Cardiac Physiology at the University of Manchester and editor-in-chief of The Journal of General Physiology (JGP).

Derek Miles Yellon is a South African-British researcher in the biomedical sciences, known for his work in cardiovascular medicine. He is a professor of molecular and cellular cardiology at University College London, and is director of the Hatter Cardiovascular Institute at University College London Hospitals and Medical School.

<span class="mw-page-title-main">Stefan D. Anker</span>

Stefan D. Anker is Head of Field “Tissue Homeostasis and Cachexia" at Charité University, Berlin, Germany. Previously, he was Professor of Innovative Clinical Trials at University Medical Center Göttingen in Germany. The main focus of the Innovative Clinical Trials department was research in the field of chronic heart failure, including the development and clinical testing of new therapies.

Gerd Heusch is a German physician, physiologist, and professor as well as chair of the Institute for Pathophysiology at the University of Essen Medical School.

Robert Roberts, is a cardiologist, geneticist, speaker and educator, who is regarded as one of the founders of molecular cardiology, pioneering the genetic causes of heart disease

<span class="mw-page-title-main">Michael L. Hess</span>

Michael L. Hess was an American professor of cardiology and physiology at the Medical College of Virginia (MCV) who was instrumental in founding the International Society for Heart and Lung Transplantation (ISHLT), of which he served as its first president.

Douglas L. Mann is an American physician. He is currently the Lewin Distinguished Professor in Cardiovascular Diseases and professor of medicine, cell biology and physiology at Washington University School of Medicine in St. Louis.

<span class="mw-page-title-main">Jason C. Kovacic</span> Australian cardiologist and physician

Jason C. Kovacic is an Australian-born cardiologist and physician-scientist; the Robert Graham Chair and Professor of Medicine, University of New South Wales; Executive Director of the Victor Chang Cardiac Research Institute in Sydney, Australia; and Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai, New York.

Catherine E. Costello is the William Fairfield Warren distinguished professor in the Department of Biochemistry, Cell Biology and Genomics, and the director of the Center for Biomedical Mass Spectrometry at the Boston University School of Medicine.

<span class="mw-page-title-main">Roberto Ferrari (cardiologist)</span> Italian Cardiologist

Roberto Ferrari is an Italian cardiologist who currently holds the position of Emeritus Professor at the University of Ferrara, where besides he was the chair of the Cardiology in the School of Medicine until the 2019-2020 academic year.

Peipei Ping is an academic specializing in cardiac physiology, system biology and data science.

References

  1. "Journal of Molecular and Cellular Cardiology - ScienceDirect.com". www.sciencedirect.com. Retrieved 2016-09-29.
  2. "Heart News & Views - International Society for Heart Research". www.ishrworld.org. Retrieved 2016-09-29.
  3. "ISHR Awards - International Society for Heart Research". www.ishrworld.org. Retrieved 2016-09-29.